Daniel E. Spratt

University Hospitals Seidman Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

5.2Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.08.034

Top 5%

4.7DataRank

Top 5%141 citations

E.S. Paulson, Brian J. Davis, Daniel E. Spratt, Todd M. Morgan, David P. Dearnaley +20 more

Papers

Driven by 67 papers — median percentile 78. Top paper: “NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer”.

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.08.034

Top 5%

4.7DataRank

Top 5%141 citations

E.S. Paulson, Brian J. Davis, Daniel E. Spratt, Todd M. Morgan, David P. Dearnaley +20 more

Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.12.035

N/A

1.1DataRank · unranked

51 citations

Huei–Chung Huang, Daniel E. Spratt, Elai Davicioni, Howard M. Sandler, William U. Shipley +17 more

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial

Annals of Oncology(2021)10.1016/j.annonc.2021.06.003

N/A

0.654DataRank · unranked

77 citations

Hsin-Chieh Huang, V. Wang, Yu‐Hui Chen, Felix Y. Feng, Robert B. Den +11 more

External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol

The Lancet Digital Health(2025)10.1016/j.landig.2025.100885

N/A

0.573DataRank · unranked

17 citations

Larissa Mendes, Vinnie Y.T. Liu, Emily Grist, Songwan Joun, Rikiya Yamashita +35 more

Transcriptome profiling of NRG Oncology/RTOG 9601: Validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.276

Top 39%

0.489DataRank

Top 39%11 citations

Howard M. Sandler, Huei–Chung Huang, Jeffry Simko, Elai Davicioni, Paul L. Nguyen +15 more

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.009

N/A

0.214DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Jeffry Simko +17 more

CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-1669

N/A

0DataRank · unranked

39 citations

Sanjana Murali, Harsimar Kaur, Thiago Vidotto, Liana B. Guedes, Daniela C. Salles +11 more

Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier

Prostate Cancer and Prostatic Diseases(2020)10.1038/s41391-020-0226-2

N/A

0DataRank · unranked

26 citations

Samuel R. Birer, R. Jeffrey Karnes, Jingbin Zhang, Elai Davicioni, Eric A. Klein +22 more

Differential expression of PSMA and 18F-fluciclovine transporter genes in metastatic castrate-resistant and treatment-emergent small cell/neuroendocrine prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.24

N/A

0DataRank · unranked

5 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +14 more

Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options

Frontiers in Oncology(2020)10.3389/fonc.2020.01616

N/A

0DataRank · unranked

2 citations

Daniel E. Spratt, Amar U. Kishan, Stephen H. Culp, Timothy N. Showalter, Nicholas G. Zaorsky

Characterization of PSMA and 18F-fluciclovine transporter gene expression in localized prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.295

N/A

0DataRank · unranked

0 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +15 more

Reply to L. C. Mendez et al and M. A. Kollmeier et al

Journal of Clinical Oncology(2020)10.1200/jco.20.02422

N/A

0DataRank · unranked

0 citations

Holly Hartman, Robert T. Dess, Daniel E. Spratt, Will Jackson

Plasma cells are enriched in localized prostate cancer in Black men and are associated with improved outcomes

Nature Communications(2021)10.1038/s41467-021-21245-w

N/A

0DataRank · unranked

114 citations

Thiago Vidotto, Yang Liu, Adrianna A. Mendes, Daniela C. Salles, Farzana A. Faisal +14 more

Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis

The Lancet Oncology(2021)10.1016/s1470-2045(20)30730-0

N/A

0DataRank · unranked

112 citations

Ralph Jiang, David G. Wallington, Gavin Jones, Samuel R. Birer, Neil Jairath +20 more

Racial disparities in prostate cancer among black men: epidemiology and outcomes

Prostate Cancer and Prostatic Diseases(2021)10.1038/s41391-021-00451-z

N/A

0DataRank · unranked

104 citations

Caroline I. Ericsson, Randy Vince, Daniel E. Spratt, Daniel J. George, Lorelei A. Mucci +1 more

Pan‐cancer analysis of prognostic metastatic phenotypes

International Journal of Cancer(2021)10.1002/ijc.33744

N/A

0DataRank · unranked

36 citations

Xi Wang, Sara M. Garrett, Eric J. Lehrer, Christine Lin, David J. DeGraff +9 more

Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer

European Urology(2021)10.1016/j.eururo.2021.03.017

N/A

0DataRank · unranked

18 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Yang Liu, Jonathan Chou +17 more

An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.12.005

N/A

0DataRank · unranked

12 citations

Nicholas G. Zaorsky, H.P. Bagshaw, Alejandro Berlín, Alison Tree, Sandra Turner +21 more

Elective Nodal Radiotherapy for Prostate Cancer: For None, Some, or all?

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.07.1699

N/A

0DataRank · unranked

4 citations

Daniel E. Spratt, Nicholas G. Zaorsky

Evaluation of predictive model performance of an existing model in the presence of missing data

Statistics in Medicine(2021)10.1002/sim.8978

N/A

0DataRank · unranked

3 citations

Jeremy M. G. Taylor, Daniel E. Spratt, R. Jeffery Karnes, Matthew J. Schipper, Pin Li

Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)

Cancer Genetics(2021)10.1016/j.cancergen.2021.08.004

N/A

0DataRank · unranked

3 citations

William L. Hwang, Jimmy A. Guo, Hannah I. Hoffman, Matthew C. Abramowitz, Ziad El-Bakouny +24 more

Exercise: A Treatment That Should Be Prescribed With Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.08.005

N/A

0DataRank · unranked

1 citations

Sara M. Garrett, Daniel E. Spratt, Paul L. Nguyen, Chris Sciamanna, KATHRYN H. SCHMITZ +1 more

Prospective randomized trial of gene expression classifier utility following radical prostatectomy (G-MINOR).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.15

N/A

0DataRank · unranked

6 citations

Linda A. Okoth, Daniel E. Spratt, Rodney L. Dunn, Felix Y. Feng, Anna Johnson +16 more

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

Nature Communications(2022)10.1038/s41467-022-30257-z

N/A

0DataRank · unranked

160 citations

Nadia Boufaied, Tarek Hallal, Avery Feit, Anna de Polo, Adrienne Luoma +30 more

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)

European Urology(2022)10.1016/j.eururo.2022.07.011

N/A

0DataRank · unranked

63 citations

Fang‐I Chu, Howard M. Sandler, Felix Y. Feng, Jason A. Efstathiou, Christopher U. Jones +37 more

Lutetium-177 DOTATATE: A Practical Review

Practical Radiation Oncology(2022)10.1016/j.prro.2022.02.002

N/A

0DataRank · unranked

42 citations

Rojano Kashani, Nicholas G. Zaorsky, Daniel E. Spratt, Ana P. Kiess, Jeff M. Michalski +4 more

Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.12.038

N/A

0DataRank · unranked

25 citations

Cédric Draulans, Amar U. Kishan, Daniel E. Spratt, Ashley E. Ross, Tobias Maurer +35 more

Genomic biomarkers to guide precision radiotherapy in prostate cancer

The Prostate(2022)10.1002/pros.24373

N/A

0DataRank · unranked

10 citations

Matthew P. Deek, Kim Van der Eecken, Alexander W. Wyatt, Amar U. Kishan, Jason K. Molitoris +11 more

Development and validation of a life expectancy calculator for US patients with prostate cancer

British Journal of Urology(2022)10.1111/bju.15740

N/A

0DataRank · unranked

8 citations

Alex K. Bryant, Yilun Sun, Will Jackson, Daniel E. Spratt, Robert T. Dess +2 more

Lutetium-177 Prostate-Specific Membrane Antigen Therapy: A Practical Review

Practical Radiation Oncology(2022)10.1016/j.prro.2022.01.012

N/A

0DataRank · unranked

7 citations

Rojano Kashani, Nicholas G. Zaorsky, Brian C. Baumann, Jeff M. Michalski, Jacqueline E. Zoberi +3 more

Identification and Validation of the Prognostic Impact of Metastatic Prostate Cancer Phenotypes

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.02.008

N/A

0DataRank · unranked

4 citations

Xi Wang, Eric J. Lehrer, Amar U. Kishan, Daniel E. Spratt, Christine Lin +7 more

External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.09.075

N/A

0DataRank · unranked

5 citations

Ting Martin, J.K. Wong, Bradley J. Stish, Robert T. Dess, Avinash Pilar +36 more

Trials in the Key of G: Building Level 1 Evidence on the Real-world Effectiveness of Prostate Biomarkers

European Urology Focus(2022)10.1016/j.euf.2022.08.001

N/A

0DataRank · unranked

3 citations

Anna Harris, Udit Singhal, Michael L. Cher, Daniel E. Spratt, Todd M. Morgan +1 more

Prostate cancer risk in African American men evaluated via digital histopathology multi-modal deep learning models developed on NRG Oncology phase III clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.108

N/A

0DataRank · unranked

6 citations

Jingbin Zhang, Andre Esteva, Osama Mohamad, Douwe van der Wal, Jeffry Simko +15 more

Candidate surrogate endpoints in advanced prostate cancer: Aggregate meta-analysis of 143 randomized trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5039

N/A

0DataRank · unranked

0 citations

Ralph Jiang, E Jaworski, Krystal Morales, Robert T. Dess, Will Jackson +15 more

Impact of Magnetic Resonance Imaging Targeting on Pathologic Upgrading and Downgrading at Prostatectomy: A Systematic Review and Meta-analysis

European Urology Oncology(2023)10.1016/j.euo.2023.04.004

N/A

0DataRank · unranked

42 citations

Xian Wu, Alexander J. Hill, Donald G. Brennan, Danly Omil-Lima, Spyridon P. Basourakos +14 more

Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer

Annals of Oncology(2023)10.1016/j.annonc.2023.04.515

N/A

0DataRank · unranked

28 citations

Amol C. Shetty, Alex Hakansson, Kim Van der Eecken, Yang Song, Y. Liu +27 more

Real-World Data: Applications and Relevance to Cancer Clinical Trials

Seminars in Radiation Oncology(2023)10.1016/j.semradonc.2023.06.003

N/A

0DataRank · unranked

20 citations

Courtney E. Pisano, Chachrit Khunsriraksakul, Daniel E. Spratt, Henry S. Park, Yilun Sun +3 more

Use of the Decipher genomic classifier among men with prostate cancer in the United States

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad052

N/A

0DataRank · unranked

17 citations

James A. Proudfoot, Angela Y. Jia, Raed Zuhour, Randy Vince, Yang Liu +29 more

Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.12.022

N/A

0DataRank · unranked

4 citations

Wee Loon Ong, Nathalie Carrier, Tahmineh Romero, Jeremy Millar, Michael L. Steinberg +14 more

FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP)

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.401

N/A

0DataRank · unranked

3 citations

Marisa Kollmeier, Dana E. Rathkopf, Richard M. Hoffman, A. Zurita-Saavedra, Daniel E. Spratt +15 more

Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled Trial

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.10.046

N/A

0DataRank · unranked

2 citations

Shawn Malone, Yilun Sun, Nicholas G. Zaorsky, Daniel E. Spratt, Scott C. Morgan +6 more

Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5094

N/A

0DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Felix Y. Feng +15 more

Determining the impact of genomic classifier testing on patient-reported quality of life after prostatectomy: Results from the G-MINOR randomized trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.345

N/A

0DataRank · unranked

0 citations

Stephanie Daignault‐Newton, Rodney Dunn, Daniel E. Spratt, Linda A. Okoth, Felix Y. Feng +15 more

Data from Targeted Nanoparticles That Deliver a Sustained, Specific Release of Paclitaxel to Irradiated Tumors

(2023)10.1158/0008-5472.c.6500841.v1

N/A

0DataRank · unranked

0 citations

Daniel E. Spratt, Alice E. van der Ende, John G. Phillips, Hongmei Wu, Vasanth Sathiyakumar +5 more

Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials

European Urology(2024)10.1016/j.eururo.2024.06.019

N/A

0DataRank · unranked

12 citations

Vinnie Y.T. Liu, Angela Y. Jia, Trevor J. Royce, Howard M. Sandler, Stephanie L. Pugh +3 more

Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.09.043

N/A

0DataRank · unranked

8 citations

Beow Y. Yeap, Jeff M. Michalski, Nora Horick, Anthony L. Zietman, John P. Christodouleas +15 more

Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial

European Urology(2024)10.1016/j.eururo.2024.09.011

N/A

0DataRank · unranked

8 citations

Stephanie Daignault‐Newton, Daniel E. Spratt, R. Dunn, Udit Singhal, Linda A. Okoth +19 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0DataRank · unranked

7 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials

European Urology Oncology(2024)10.1016/j.euo.2024.10.017

N/A

0DataRank · unranked

2 citations

Paul L. Nguyen, James A. Proudfoot, Yang Liu, Alan Dal Pra, Daniel E. Spratt +16 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data Set

European Urology Oncology(2024)10.1016/j.euo.2024.04.017

N/A

0DataRank · unranked

2 citations

Helen H. Sun, Udit Singhal, Fredrick R. Schumacher, Erika Trapl, Johnie Rose +9 more

The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials

The Lancet Oncology(2025)10.1016/s1470-2045(24)00720-4

N/A

0DataRank · unranked

28 citations

Parsa Jamshidian, Alison Tree, Emma Hall, David P. Dearnaley, Jeff M. Michalski +23 more

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

Cell(2025)10.1016/j.cell.2025.07.042

N/A

0DataRank · unranked

24 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, James A. Proudfoot +42 more

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium

The Lancet Oncology(2025)10.1016/s1470-2045(25)00034-8

N/A

0DataRank · unranked

20 citations

Yilun Sun, Alison Tree, Emma Hall, David P. Dearnaley, Charles Catton +29 more

Evolution of Image Guidance and Adaptive Radiation Therapy for Localized Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2024.12.011

N/A

0DataRank · unranked

6 citations

Joan Lee, Maitry Patel, Nicholas G. Zaorsky, Raed Zuhour, Rojano Kashani +5 more

The Benefit of Short-Term Androgen Deprivation Therapy with Radiation Therapy for Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.01.022

N/A

0DataRank · unranked

7 citations

Daniel E. Spratt, Phouc T. Tran, Daniel Krauss, Anthony V. D’Amico, Paul L. Nguyen +1 more

Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer

Prostate Cancer and Prostatic Diseases(2025)10.1038/s41391-025-01062-8

N/A

0DataRank · unranked

1 citations

Ralph Jiang, James A. Proudfoot, Elizabeth C. Chase, Krithika Suresh, Elai Davicioni +22 more

Future directions in the evaluation and management of newly diagnosed metastatic cancer

Critical Reviews in Oncology/Hematology(2025)10.1016/j.critrevonc.2025.104631

N/A

0DataRank · unranked

1 citations

Chachrit Khunsriraksakul, Sara M. Garrett, Daniel M. Trifiletti, Jason P. Sheehan, Matthias Gückenberger +24 more

Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical Trial

European Urology(2025)10.1016/j.eururo.2025.09.4149

N/A

0DataRank · unranked

1 citations

Jesus E. Juarez Casillas, Paul Sargos, Tahmineh Romero Kalbasi, Sylvie Chabaud, Meryem Brihoum +22 more

Physician Body-Site Expertise and Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy Rounds Review

Advances in Radiation Oncology(2025)10.1016/j.adro.2025.101880

N/A

0DataRank · unranked

0 citations

Krithika Suresh, Aleksandar F. Dragovic, Mary Feng, Jason W.D. Hearn, Reshma Jagsi +6 more

Downregulation of ANPEP Is Associated with Aggressive Prostate Cancer and Poor Disease-specific Outcomes

European Urology Open Science(2025)10.1016/j.euros.2025.12.011

N/A

0DataRank · unranked

0 citations

Purvish Trivedi, Shivanshu Awasthi, Amparo Serna, Jasreman Dhillon, Christopher J. Sweeney +14 more

Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.11.064

N/A

0DataRank · unranked

26 citations

Vinayak Muralidhar, Melaku A. Arega, Amar U. Kishan, Daniel E. Spratt, Robert T. Dess +8 more

Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes

Journal of Clinical Medicine(2020)10.3390/jcm9061973

N/A

0DataRank · unranked

21 citations

Mark Farha, Sudharsan Srinivasan, Ruple Jairath, Michael D. Green, Robert T. Dess +8 more

Genomic and clinical characterization of stromal infiltration markers in prostate cancer

Cancer(2020)10.1002/cncr.32688

N/A

0DataRank · unranked

14 citations

Mohammed Alshalalfa, Shuang G. Zhao, Himisha Beltran, William S. Chen, Fallon Chipidza +11 more

Changes in prostate‐specific antigen at the time of prostate cancer diagnosis after Medicaid expansion in young men

Cancer(2020)10.1002/cncr.32930

N/A

0DataRank · unranked

14 citations

Amanda X. Vo, Anuj S. Desai, Jim C. Hu, Daniel E. Spratt, Edward M. Schaeffer +1 more

Detecting TRA-1–60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging Agent

Molecular Pharmaceutics(2020)10.1021/acs.molpharmaceut.9b01181

N/A

0DataRank · unranked

7 citations

Akhila N. W. Kuda‐Wedagedara, Madison N. Wicker, Daniel E. Spratt, William M. Schopperle, Elisabeth I. Heath +2 more

Daniel E. Spratt

Indexed papers

Top data-sharing exemplar

Papers